These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33064025)

  • 1. Robust Determination of the Optimal Continuous Glucose Monitoring Length of Intervention to Evaluate Long-Term Glycemic Control.
    Herrero P; Alalitei A; Reddy M; Georgiou P; Oliver N
    Diabetes Technol Ther; 2021 Apr; 23(4):314-319. PubMed ID: 33064025
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling Duration.
    Akturk HK; Herrero P; Oliver N; Wise H; Eikermann E; Snell-Bergeon J; Shah VN
    Diabetes Technol Ther; 2022 Oct; 24(10):749-753. PubMed ID: 35653736
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
    Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
    Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to Data Loss of Glycemic Variability Measurements in Long-Term Continuous Glucose Monitoring.
    Kucharski P; Pagacz K; Szadkowska A; Młynarski W; Romanowski A; Fendler W
    Diabetes Technol Ther; 2018 Dec; 20(12):833-842. PubMed ID: 30403500
    [No Abstract]   [Full Text] [Related]  

  • 6. Time in Specific Glucose Ranges, Glucose Management Indicator, and Glycemic Variability: Impact of Continuous Glucose Monitoring (CGM) System Model and Sensor on CGM Metrics.
    Pleus S; Kamecke U; Waldenmaier D; Link M; Zschornack E; Jendrike N; Haug C; Freckmann G
    J Diabetes Sci Technol; 2021 Sep; 15(5):1104-1110. PubMed ID: 32513087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing blood glucose variability using new metrics with continuous glucose monitoring data.
    Marling CR; Shubrook JH; Vernier SJ; Wiley MT; Schwartz FL
    J Diabetes Sci Technol; 2011 Jul; 5(4):871-8. PubMed ID: 21880228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic control and blood gas sampling frequency during continuous glucose monitoring in the intensive care unit: A before-and-after study.
    Mårtensson J; Cutuli S; Yanase F; Ancona P; Toh L; Osawa E; Bellomo R
    Acta Anaesthesiol Scand; 2023 Jan; 67(1):86-93. PubMed ID: 36263915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Glucose Control Metrics by Discriminant Ratio.
    Moscardó V; Herrero P; Reddy M; Hill NR; Georgiou P; Oliver N
    Diabetes Technol Ther; 2020 Oct; 22(10):719-726. PubMed ID: 32163723
    [No Abstract]   [Full Text] [Related]  

  • 10. Early Glycemic Control Assessment Based on Consensus CGM Metrics
    Mohebbi A; Bohm AK; Tarp JM; Lind Jensen M; Bengtsson H; Morup M
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():1269-1275. PubMed ID: 34891517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential Continuous Glucose Monitoring Metrics: The Principal Dimensions of Glycemic Control in Diabetes.
    Montaser E; Fabris C; Kovatchev B
    Diabetes Technol Ther; 2022 Nov; 24(11):797-804. PubMed ID: 35714355
    [No Abstract]   [Full Text] [Related]  

  • 13. A cognitive behavioral therapy intervention to reduce fear of hypoglycemia in young adults with type 1 diabetes (FREE): study protocol for a randomized controlled trial.
    Martyn-Nemeth P; Duffecy J; Quinn L; Park C; Mihailescu D; Penckofer S
    Trials; 2019 Dec; 20(1):796. PubMed ID: 31888691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles.
    Tweden KS; Deiss D; Rastogi R; Addaguduru S; Kaufman FR
    Diabetes Technol Ther; 2020 May; 22(5):422-427. PubMed ID: 31697182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.
    El-Laboudi AH; Godsland IF; Johnston DG; Oliver NS
    Diabetes Technol Ther; 2016 Dec; 18(12):806-812. PubMed ID: 27996321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring.
    Xing D; Kollman C; Beck RW; Tamborlane WV; Laffel L; Buckingham BA; Wilson DM; Weinzimer S; Fiallo-Scharer R; Ruedy KJ;
    Diabetes Technol Ther; 2011 Mar; 13(3):351-8. PubMed ID: 21299401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets.
    Rossi A; Venema A; Haarsma P; Feldbrugge L; Burghard R; Rodriguez-Buritica D; Parenti G; Oosterveer MH; Derks TGJ
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3612-e3623. PubMed ID: 35786777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of glycemic control with continuous glucose monitoring on atheroma progression: rationale and design of the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Mellitus (OPTIMAL).
    Kataoka Y; Hosoda K; Makino H; Matsubara M; Matsuo M; Ohata Y; Koezuka R; Tamanaha T; Tomita T; Honda-Kohmo K; Noguchi M; Son C; Nishimura K; Asaumi Y; Miyamoto Y; Noguchi T; Yasuda S
    Cardiovasc Diagn Ther; 2019 Oct; 9(5):431-438. PubMed ID: 31737515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes.
    Avari P; Moscardo V; Jugnee N; Oliver N; Reddy M
    J Diabetes Sci Technol; 2020 May; 14(3):567-574. PubMed ID: 31375042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.